Anti-SHPK monoclonal antibody

Pre-made anti-SHPK monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SHPK/SHPK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1640-Ab-1/ GM-Tg-hg-IP1640-Ab-2Anti-Human SHPK monoclonal antibodyHuman
GM-Tg-rg-IP1640-Ab-1/ GM-Tg-rg-IP1640-Ab-2Anti-Rat SHPK monoclonal antibodyRat
GM-Tg-mg-IP1640-Ab-1/ GM-Tg-mg-IP1640-Ab-2Anti-Mouse SHPK monoclonal antibodyMouse
GM-Tg-cynog-IP1640-Ab-1/ GM-Tg-cynog-IP1640-Ab-2Anti-Cynomolgus/ Rhesus macaque SHPK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1640-Ab-1/ GM-Tg-felg-IP1640-Ab-2Anti-Feline SHPK monoclonal antibodyFeline
GM-Tg-cang-IP1640-Ab-1/ GM-Tg-cang-IP1640-Ab-2Anti-Canine SHPK monoclonal antibodyCanine
GM-Tg-bovg-IP1640-Ab-1/ GM-Tg-bovg-IP1640-Ab-2Anti-Bovine SHPK monoclonal antibodyBovine
GM-Tg-equg-IP1640-Ab-1/ GM-Tg-equg-IP1640-Ab-2Anti-Equine SHPK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1640-Ab-1/ GM-Tg-hg-IP1640-Ab-2; GM-Tg-rg-IP1640-Ab-1/ GM-Tg-rg-IP1640-Ab-2;
GM-Tg-mg-IP1640-Ab-1/ GM-Tg-mg-IP1640-Ab-2; GM-Tg-cynog-IP1640-Ab-1/ GM-Tg-cynog-IP1640-Ab-2;
GM-Tg-felg-IP1640-Ab-1/ GM-Tg-felg-IP1640-Ab-2; GM-Tg-cang-IP1640-Ab-1/ GM-Tg-cang-IP1640-Ab-2;
GM-Tg-bovg-IP1640-Ab-1/ GM-Tg-bovg-IP1640-Ab-2; GM-Tg-equg-IP1640-Ab-1/ GM-Tg-equg-IP1640-Ab-2
Products NameAnti-SHPK monoclonal antibody
Formatmab
Target NameSHPK
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SHPK monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1640-Ag-1Recombinant multi-species SHPK/ CARKL/ SHK protein


    Target information

    Target IDGM-IP1640
    Target NameSHPK
    Gene ID23729,74637,287479,721465,491219,101093154,511999
    Gene Symbol and Synonyms4930431K22Rik,CARKL,SHK,SHPK
    Uniprot AccessionQ9UHJ6
    Uniprot Entry NameSHPK_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197417
    Target ClassificationN/A

    The target: SHPK, gene name: SHPK, also named as CARKL, SHK. The protein encoded by this gene has weak homology to several carbohydrate kinases, a class of proteins involved in the phosphorylation of sugars as they enter a cell, inhibiting return across the cell membrane. Sequence variation between this novel gene and known carbohydrate kinases suggests the possibility of a different substrate, cofactor or changes in kinetic properties distinguishing it from other carbohydrate kinases. The gene resides in a region commonly deleted in cystinosis patients, suggesting a role as a modifier for the cystinosis phenotype. The genomic region is also rich in Alu repetitive sequences, frequently involved in chromosomal rearrangements. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.